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Members of the cytochrome P450 (cyt P450) superfamily of enzymes oxidize a wide array of endogenous and xenobiotic substances to prepare
them for excretion. Most of the drugs in use today are metabolized in part by a small set of human cyt P450 isozymes. Consequently, cyt P450s
have for a long time received a lot of attention in biochemical and pharmacological research. Cytochrome P450 receives electrons from
cytochrome P450 reductase and in selected cases from cytochrome b5 (cyt b5). Numerous structural studies of cyt P450s, cyt b5, and their
reductases have given considerable insight into fundamental structure–function relationships. However, structural studies so far have had to rely
on truncated variants of the enzymes to make conventional X-ray crystallographic and solution-state NMR techniques applicable. In spite of
significant efforts it has not yet been possible to crystallize any of these proteins in their full-length membrane bound forms. The truncated parts of
the enzymes are assumed to be α-helical membrane anchors that are essential for some key properties of cyt P450s. In the present contribution we
set out with a basic overview on the current status of functional and structural studies. Our main aim is to demonstrate how advanced modern
solid-state NMR spectroscopic techniques will be able to make substantial progress in cyt P450 research. Solid-state NMR spectroscopy has
sufficiently matured over the last decade to be fully applicable to any membrane protein system. Recent years have seen a remarkable increase in
studies on membrane protein structure using a host of solid-state NMR techniques. Solid-state NMR is the only technique available today for
structural studies on full-length cyt P450 and full-length cyt b5. We aim to give a detailed account of modern techniques as applicable to cyt P450
and cyt b5, to show what has already been possible and what seems to be viable in the very near future.
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1.1. Cytochromes P450 and b5
The cytochromes P450 are a ubiquitous superfamily of more
than 6500 genes found in bacteria, fungi, plants, and animals.
Three of the mammalian cyt P450 families constitute the prin-
cipal enzymes of xenobiotic metabolism in man and are
responsible for the oxidation of the literally thousands of
chemicals, including thousands of drugs, compounds in our
food, carcinogens and environmental pollutants to which man is
exposed. Breakdown of unwanted endogenous and xenobiotic
substances in the liver is the most important pathway of freeing
the organism from toxic or otherwise harmful chemical
influences. Other members of the human cytochrome P450
(cyt P450) family are involved in the biosynthesis of sterols,
fatty acids, eicosanoids, and vitamins. The cytochromes P450,
whose oxidase activity requires two electrons and two protons
to activate oxygen, carry out their function mainly in the
endoplasmic reticulum of liver cells. They are mixed-function
monooxygenases, most often adding a single hydroxyl group to
their substrates; they also catalyze other reactions. The
hydroxylated substrate has increased hydrophilicity, making it
more water soluble and easier to be excreted by the kidney.
Cytochrome P450 receives electrons from cytochrome P450
reductase (CPR) and cytochrome b5 (cyt b5). Cyt b5 in turn
receives electrons from either cytochrome b5 reductase (b5R) or
cytochrome P450 reductase. Fig. 1 gives an overview of the
sizes and shapes of these molecules as determined in X-ray
crystallography or solution-state NMR studies. Surface repre-sentations were generated using the molecular modeling
software VMD (‘Virtual Molecular Dynamics’ [1]). Remark-
ably, all four molecules under physiological conditions possess
hydrophobic domains that serve to anchor the molecules to the
endoplasmic reticulum. Since these long hydrophobic domains
prohibit application of standard techniques of structural biology,
they have been cleaved off in most structural studies published
to date. This situation is not fully satisfying since it has been
observed numerous times that the transmembrane domains are
essential for the four enzymes to carry out their respective
functions.
The present contribution aims to demonstrate how solid-state
NMR spectroscopy will help to overcome the limitations posed
to structural studies of full-length cyt P450 and cyt b5 today.
Since this article focuses on the prospect of subjecting
cytochromes P450 and b5 to solid-state NMR studies, we will
briefly emphasize the current state of the molecular biological
and functional studies of the cytochromes. We will focus on the
2B4 isozyme of cyt P450 and on rabbit cyt b5, since we
currently investigate these specific molecules in our laboratories
by means of solid-state NMR spectroscopy.
1.2. Structural biology of membrane proteins
Membrane proteins form the most exciting frontier in
structural biology today. Although membrane proteins make
up 30% of typical eukaryotic genomes [2], only a very limited
number of high-resolution three-dimensional structures are
currently available. An overview of solved structures of mem-
brane proteins can be found on the webpages of Hartmut Michel
Fig. 2. Schematic representation of the interaction between cyt P450, cyt b5, and
their respective reductases. Note that cyt b5 acts as an electron donor for other
enzymes, including fatty acid desaturases. The functional role of cyt b5 is
contested with human cyts P450, but in the case of rabbit cyt P450 2B4 it
definitely involves electron transfer [11].
Fig. 1. Model structures of cyt b5, cyt P450, and their reductases. The models were constructed from the crystallographic or solution-state NMR structures of soluble
domains without the hydrophobic membrane anchors. The pdb identification numbers of the underlying structures are indicated alongside the molecules' names (top).
The hypothetical alignment of the soluble fragment of cyt P450 2B4 was taken from the OPM database. The surface representations were generated with VMD [1].
Color coding: cyt b5 (pink), heme (red), cyt P450 (green), NADPH (blue), NAD(P)H-binding domain (light blue), FAD (yellow), FAD-binding domain (light yellow),
FMN-binding domain (orange).
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html) and Stephen White (blanco.biomol.uci.edu/Membrane_
Proteins_xtal.html). The obstacles in the structural study of
membrane proteins are mostly due to their intrinsic biophysical/
biochemical properties. Namely, their highly hydrophobic
nature makes them prone to misfolding and aggregation and
makes it very difficult to obtain good quality crystals for studies
using X-ray crystallography. On the other hand, the slow
reorientation of membrane proteins makes them not suitable for
structure determination using well-established solution-state
NMR spectroscopy [3]. Nevertheless, the number of structures
determined on membrane proteins has grown exponentially
after the first structure was published in 1985, thus equaling the
rate at which structure determinations of soluble proteins
emerged earlier [4].
1.3. Solid-state NMR spectroscopy
Solution-state NMR spectroscopy has been very successful
in solving the structures of water-soluble proteins [5,6]. Today,
solid-state NMR spectroscopy is well on the way to being an
equally successful approach to the study of insoluble, non-
crystalline or amorphous biomolecules like membrane proteins
[7]. In fact, solid-state NMR today is ready to tackle any
membrane protein of biological, medical or pharmaceutical
interest. Methods have sufficiently evolved to achieve excellent
spectral resolution, to identify a majority of resonances in se-
quential assignments, and to acquire non-trivial geometrical
constraints that report on protein tertiary structure. The re-
maining limiting factors are the quality and homogeneity
attainable in protein/lipid preparations, and sensitivity issues
[8]. In the upcoming years, we expect reports of de novo
structure determinations of membrane proteins using solid-state
NMR to become increasingly common.
Our laboratories have taken the first steps toward structural
studies of membrane-associated cytochrome P450 and cyto-chrome b5. The present review will present an overview of the
advanced solid-state NMR methods that are readily applicable
to these proteins and that, in our expectation, should soon allow
us to answer important fundamental questions on the way
structure and function are interdependent in the two proteins,
and in their physiological interactions.
2. Biochemistry of cytochromes P450 and b5, and their
reductases
2.1. An electron transfer network enables substrate oxidation
The oxidation of small endo- and xenobiotic substances in the
liver is made possible by an intricate chain of proteins that
donate electrons to the cytochrome P450 (abbreviated cyt P450
or CYP) superfamily of enzymes, that catalyze the actual
oxidation of substrate. Fig. 2 gives a schematic of the pathways
of electron transfer. Nicotinamide adenine dinucleotide phos-
phate (NADPH) and nicotinamide adenine dinucleotide
(NADH) are the source of electrons that reduce the enzymes
cyt P450 reductase and cyt b5 reductase, respectively. These two
enzymes pass on their acquired electrons to, respectively, cyt
Fig. 3. General schematic of the catalytic cycle of cytochrome P450s. The
substrate is denoted ‘RH’, color coding indicates oxidation states of the heme
iron.
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protein. Cyt P450 reductase also reduces cyt b5. Once oxyferrous
cyt P450 has acquired an electron, it is able to catalyze the
oxidation of its substrate, denoted ‘R’ in Fig. 2. In the endo-
plasmic reticulum, cyt P450 and cyt b5 are found in approxi-
mately equal amounts, while only one copy of cytochrome P450
reductase is found for 10 to 20 cyt P450 molecules.
The role of cyt b5 in the catalytic function of cyt P450 in
microsomes is not fully understood, although antibodies to cyt
b5 can inhibit the microsomal activity of cyt P450 2B4 and 3A4,
suggesting it is important in vivo [9,10]. In a purified, recons-
tituted system, cyt b5 may stimulate, inhibit, or not affect the
activity of cyt P450. This rather puzzling behavior of cyt b5 can
be better understood because of recent findings that demon-
strated that under single turnover conditions, cyt b5 catalyzes
product formation faster than cyt P450 reductase, leaving less
time for side product formation and that cyt b5 and reductase
compete for a binding site on the proximal surface of cyt P450
[11]. The results under single turnover conditions where all
these proteins are present provide an explanation for the puz-
zling observations and variety of effects under steady-state
conditions. At low concentrations of cyt b5, the activity of cyt
P450 2B4 is stimulated because the efficiency of catalysis
increases due to less side product formation. In contrast, at high
concentrations, cyt b5 binds to cyt P450 2B4 and prevents the
reductase from reducing the ferric cyt P450 and initiating
catalysis. There is no change in activity when the stimulatory
and inhibitory activities are equal [11,12]. In addition, cyt b5 not
only contributes to the enzymatic activity of cyt P450, but also
donates electrons to several other important enzymes, including
fatty acid desaturates [13,14].
2.2. Cytochrome P450
Corresponding to the large number of substrates that the cyt
P450 enzymes metabolize, there is a large number of cyt P450
isoforms expressed. The human genome contains 57 putatively
functional CYP genes [15]. All CYP enzymes oxidize their
substrates, but they vary considerably in substrate specificity.
Some of them oxidize only a few closely related substrates,
others can metabolize a whole array of vastly different
substrates. The isozymes with a limited substrate specificity in
general are involved in the biosynthesis or degradation of sterols
and other endobiotics and may be associated with a specific
phenotype. For example, CYP 7A1 catalyzes the hydroxylation
of cholesterol at the 7α position. This reaction is the rate limiting
step in bile acid synthesis in man, and a deficiency of CYP 7A1
results in a hypercholesterolemic phenotype with early onset
atherosclerotic disease [16,17]. On the other hand, roughly a
quarter of the 57 human CYP isoforms is assumed to be involved
primarily in the metabolism of xenobiotic chemicals [18]. The
chemical aspects of the catalyzed complex reactions have been
reviewed [19]. It seems possible to use directed evolution to
engineer novel CYP isoforms to catalyze new, industrially
interesting reactions [20].
CYP enzymes are especially important in the metabolism of
drugs; they are the enzyme systems most commonly involved intheir biodegradation. In fact, they contribute to the metabolism
of ∼70% of the drugs in use today. An overview of human
CYPs can be found in the literature [21]. Among the CYPs
breaking down drugs, the isoform CYP 3A4 is most abundant, it
contributes to the metabolism of approximately half of the drugs
that are in use today. Its enzyme kinetics, substrates and
inhibitors are of special interest [22]. The human cyt P450
enzymes may (a) activate or inactivate a drug, or (b) detoxify or
make a compound more toxic/carcinogenic [18]. The individual
set of CYP enzymes that an individual possesses, and their
specific expression levels, determine the metabolic reaction
every individual shows when treated with a drug. Thus, a future
pharmacological aim is to account for personal genetic
polymorphisms and differences in expression when choosing
and administering a drug [23]. It is equally important to study
CYPs in animals, in order to develop relevant and reliable
models of human drug metabolism [24].
CYP enzymes oxidize their substrate by means of an oxy-
ferryl π cation heme intermediate [25]. Fig. 3 gives an overview
over the enzymatic cycle. Important steps in generating the
active oxyferryl π cation intermediate are the binding of the
substrate (marked ‘RH’ in the figure), reduction of the heme
iron to Fe2+, binding of molecular oxygen, reduction of the
oxyferrous complex, sequential delivery of two protons, hetero-
lytic cleavage of the oxygen molecule to form the putative
reactive oxyferryl π cation intermediate and water. The resulting
oxyferryl intermediate then inserts an oxygen into the C–H
bond of the substrate.
Two side reactions occur that diminish the efficiency of
oxidation by cyt P450. In autooxidation, a superoxide anion O2
−
is lost, while in uncoupling a molecule of H2O2 is lost. In both
cases, the enzyme returns to the ferric state. Both side pathways
are indicated in Fig. 3. The extent of uncoupling is different for
different cyt P450 isoforms. This may be related to the differ-
ences in substrate specificity seen between different isoforms; it
may be argued that an increase in uncoupling may be a trade-off
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by cyt b5. The mechanism by which this effect occurs has only
recently been elucidated for cyt P450 2B4.
Catalysis by cyt P450 is 10- to 100-fold faster in the presence
of cyt b5 than in the presence of cyt P450 reductase leaving less
time for autooxidation of the oxyferrous cyt P450 [11,26,27].
Although it is not known whether cyt b5 has this effect on other
isozymes than CYP 2B4, it is likely that future studies will
demonstrate that cyt b5 also affects selected xenobiotic human
cyt P450s in this manner. The major drug metabolizing human
cyt P450, 3A, is stimulated by cyt b5.
Functional studies of microsomal cyt P450s require the
presence of lipid, although its exact role in enhancing catalysis
is not understood at this time. The lipid does not appear to be
required to form a bilayer. One of the significant challenges in
studying the activity, mechanism of action, and the interactions
of cyt P450 with its two redox partners, cyt b5 reductase and cyt
P450 reductase, is the inability to gather structural data of the
full-length protein in a bilayer environment similar to that found
in cells in vivo. Solid-state NMR is, at present, the only high-
resolution technique capable of providing information about
how cyt P450 interacts with the membrane.
2.3. Structural studies on truncated variants of cytochrome
P450
Numerous isoforms of cyt P450 from many species have
been subjected to structural investigations. However, most of
these proteins possess an N-terminal transmembrane domain
which, due to its hydrophobic nature, prohibits the formation of
crystals amenable for X-ray crystallographic studies. Most
crystallographic studies to date solved this problem by cleaving
off the hydrophobic domain and investigating only the soluble
cleavage product. The soluble catalytic domain of membrane-
bound enzymes displays catalytic function albeit at a lower level
than the intact protein. The large molecular size of membrane-
bound cyt P450s (approximately 50 kDa) and its tendency to
aggregate has so far prohibited NMR spectroscopic investiga-
tions in solution. Cyt P450 camphor, a soluble bacterial protein,
has been studied by solution NMR spectroscopy [28,29].Fig. 4. Three views of the crystal structure of CYP 2B4 bound to the substrate chlorop
(B) Rotated 90° to the left. (C) Same as panel B with transparent representation of
substrate. The molecular representations were generated with VMD [1].Bacterial cyt P450 enzymes, which are predominantly
soluble proteins, were the first to be crystallized [30]. Hasemann
et al. [31] give a general review of the structural features found
in bacterial cyt P450s. The first crystal structure for a micro-
somal cyt P450 was not determined until 2000, 15 years after
the structure of the first soluble cyt P450, for the enzyme CYP
2C5 (pdb-id 1DT6 [32]). Genetic engineering was necessary to
obtain the catalytic domain of the protein in soluble and
monomeric form amenable for crystallization [33]. A recent,
short review by Johnson and Stout [34] gives a general
overview of structural features in mammalian cyt P450s and
their putative interaction with the membrane; the relationship
between the structure and chemistry of cyt P450 was reviewed
by Denisov et al. [35]; Williams et al. [36] gave a comparison of
structural details found in microbial and mammalian cyt P450s.
For CYP 2B4, a cyt P450 isoform of 55.8-kDa molecular
weight that is investigated in our laboratories, three crystal
structures are available. The first structure (pdb-id 1SUO [37])
shows a complex with the small inhibitor 4-(4-chlorophenyl)-
imidazole. Fig. 4 shows three different views of that structure.
Some structural features are conserved in all cyt P450s. The
structure consists of twelve α-helices (labeled A to L) and four
β-sheets (1 to 4). The prosthetic heme group is buried in the
center of the molecule. There are generally two sides to cyt
P450, referred to as the proximal and distal sides. The proximal
side, where the heme is ligated to the thiolate of a conserved
cysteine, accepts the redox partner protein and is highly con-
served, while the distal side binds O2 and substrate and, due to
the broad range of substances metabolized by cyt P450s, shows
strong variability.
Two other crystal structures were determined for CYP 2B4,
one in the presence of an azole inhibitor molecule, whose
nitrogen binds the heme. The second crystal structure with two
molecules of CYP 2B4 in the asymmetric unit (1PO5 [38])
shows an ‘open conformation’, with a His sidechain from one
molecule binding to the heme iron of the other. This confor-
mation demonstrates the extraordinary flexibility of xenobiotic-
metabolizing cyt P450s and its importance for substrate binding
in general [39]. The crystal structure of CYP 2B4 complexed
with a bulky azole inhibitor (2BDM [40]), the broad-spectrumhenylimidazole (shown in blue, pdb-id 1SUO). (A) View from the proximal side.
secondary structure elements, showing the spatial relation between heme and
Fig. 5. Topology of full-length cytochrome b5.
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somewhat more ‘open’ than the chlorophenylimidazole-bound
structure. The most plastic regions, which are involved in sub-
strate access or substrate binding, make it possible for a single
xenobiotic-metabolizing cyt P450 to oxidize a wide variety of
substrates.
It needs to be noted that no crystal structure can give any
information about the interaction of a cyt P450 enzyme with the
surrounding lipid bilayer. Williams et al. [32] model a putative
orientation of CYP 2C5 (pdb-id 1DT6) in the membrane that is
based on antibody binding and proteolysis studies. It shows an
upright orientation of the triangular soluble moiety of cyt P450.
An orientation prediction carried out on the truncated micro-
somal protein CYP 2C5 (1DT6) with the orientation prediction
algorithm OPM [41] reaches a similar conclusion. Of special
interest is the FG-loop of cyt P450 which has been speculated to
be immersed in the lipid bilayer and to regulate substrate access
to the active site. The data on this point are controversial with
antibody and protease susceptibility experiments suggesting
insertion of the FG-loop in the membrane, but the lack of
quenching of tryptophans in the FG-loop by nitroxide spin-label
modified phospholipids indicating it is not inserted into the
membrane [42].
2.4. Cytochrome b5
Cytochrome b5 (cyt b5) is a 16.7-kDa electron transfer
protein found in the endoplasmic reticulum (ER) of liver cells
and, in a soluble form, in erythrocytes [43]. The erythrocyte
form of cyt b5 reduces methemoglobin [44]. The membrane-
bound form of cyt b5 found in the endoplasmic reticulum is also
referred to as microsomal cyt b5, since it is isolated from whole
cells in the microsomal fraction. Two functional genes code for
the two forms of cyt b5 in rabbit [45]. Sequence alignments for
cyt b5 as found in a variety of species are given in several
publications [13,46,47]. The soluble domain of cyt b5 shows
considerable sequence homology to both hemoglobin and
myoglobin [48]. The physiological functions and biochemical
properties of cyt b5 have been reviewed [13,14]. Both forms of
cyt b5 carry a prosthetic heme group and can exist in oxidized
and reduced states. Physiologically, cyt b5 can be reduced by
both cyt b5 reductase and cyt P450 reductase [49]. Intracellular
sorting of full-length cyt b5 has been investigated [50]. Ex-
pression of full-length cyt b5 in Escherichia coli has greatly
facilitated functional, structural, and mutagenesis studies
[51,52].
Fig. 5 illustrates a cartoon representation of the topology of
microsomal cyt b5. It consists of three domains: a soluble
domain that can be cleaved off using trypsin. This domain
carries the heme group and has been the object of many
structural studies (see below). In the full-length microsomal
protein, the soluble domain is anchored to the ER membrane by
a hydrophobic, α-helical membrane anchor at its carboxyl
terminus. Possible conformations of the cyt b5 membrane
anchor, or ‘tail’, have been reviewed [46]. Most likely, it spans
the bilayer of the endoplasmic reticulum as a transmembrane
α-helix [53]. The soluble domain and membrane anchor areconnected by a short linker region. The exact nature of the linker
region influences how cyt b5 interacts with cyt P450 [47].
For reasons of completeness, we add the full-length amino
acid sequence of microsomal cyt b5 from rabbit, which is the
object of structural studies in our laboratories. The putative
extension of the α-helical membrane anchor is underlined:
MAAQSDKDVK10-YYTLEEIKKH20-NHSKSTWLIL30-
HHKVYDLTKF40-LEEHPGGEEV50-LREQAGGDAT60-
ENFEDVGHST70-DARELSKTFI80-IGELHPDDRS90-
KLSKPMETLI100-TTVDSNSSWW110 -TNWVIPAISA120-
LIVALMYRLY130-MADD
2.5. Structural studies on truncated variants of cytochrome b5
The hydrophobic transmembrane segment of full-length cyt
b5 can easily be cleaved off using trypsin. Numerous studies
have subjected the remaining soluble domain to structural
experiments. It is highly soluble in aqueous solution and readily
forms crystals. As an example, for bovine cyt b5, there are
numerous NMR structure determinations (pdb-id 1WDB [54],
superseded by a later structure 1HKO which is not accompanied
by a journal publication) as well as an X-ray crystallographic
structure (1CYO [55]). The first structure determination for
human cyt b5 currently awaits publication (2I96, no accompa-
nying journal publication as ofMay 2007). AnX-ray structure of
cyt b5 from house fly allows comparison between cyt b5 from
insects and vertebrates [56]. For rabbit cyt b5, which is currently
under investigation in our laboratories, a single NMR structure
determination was carried out (1DO9 [57]). Fig. 6 shows the
structure of rabbit cyt b5 as a representative for all cyt b5 variants
investigated. The prosthetic heme group (shown red in Fig. 6) is
‘sandwiched’ in a cleft between two helix–turn–helix motifs. A
three-stranded β-sheet (green) ‘ties together’ the helices. The
structure shows another α-helix at the N-terminus. The C-
terminal residues that form the connection to the (cleaved off)
transmembrane domain are disordered in most crystal structures.
To fully appreciate solution-state NMR spectroscopic work
carried out on soluble cyt b5, it is important to note that the
heme prosthetic group represents a paramagnetic center. This
center exerts a strong magnetic effect on the surrounding
portions of the protein. Special methods had to be applied to
Fig. 6. Structural elements of the soluble form of rabbit cyt b5, as seen in the
solution-state NMR structure determination 1DO9. Shown in red is the heme
prosthetic group which is held in the cleft between two helix–turn–helix motifs.
These are ‘tied together’ by a three-stranded β-sheet (green). The C-terminal
residues (lower right) are disordered in this structure; in full-length cyt b5 they
form the link to the transmembrane anchor domain. The representation was
generated with VMD [1].
3241U.H.N. Dürr et al. / Biochimica et Biophysica Acta 1768 (2007) 3235–3259transfer assignments between oxidized and reduced forms of cyt
b5 [58]. Among others, this was done for pig and calf cyt b5
[59], and for rat cyt b5 [60]. As a result, it was possible to study
differences in physical properties of both forms [61]. It is
generally possible to use pseudocontact shifts caused by the
paramagnetic center as structural constraints in structure refine-
ment calculations [62,63].
We want to point out that the broad range of experience that
has been gained in solution-state NMR studies of truncated cyt
b5 will be extremely helpful in the future interpretation of data
to be gathered in solid-state studies of full-length cyt b5.
Comparison with solution-state NMR data will not only be
helpful in the assignment of solid-state NMR data, but will also
give immediate information on those regions of the protein that
change their properties in a membrane environment.
General biophysical methods were used to investigate the
extraordinary stability of cyt b5 and its folding and unfolding
pathways [64]. Only recently, molecular dynamics simulations
have been employed to study the influence of point mutations
on molecular flexibility [65]. The structure of the apo-protein
lacking the prosthetic heme group has been determined (pdb-ids
1IET and 1IEU [66]). It shows that large portions of cyt b5 are
unstructured in the absence of heme [66,67].
The interaction of soluble cyt b5 with cytochrome c, a
structurally similar electron carrier protein from the respiratory
chain, forms a special area of investigation [68]. Although this
particular interaction has only very limited physiological rele-
vance, it is of interest because it represents the most simple
model system for the study of electron transfer. NMR spectro-
scopic studies in solution were able to pinpoint residues whose
spectral properties change upon binding to cytochrome c, thus
identifying a binding interface between both proteins [69–71].
Likewise, similar interactions of cyt b5 with myoglobin and
hemoglobin have been investigated [72].
2.6. Interaction between cyt P450 and cyt b5
The interaction between cyt P450 and cyt b5 is of great
interest. Note that only the full-length membrane-binding formof cyt b5 interacts with microsomal cyt P450s. Binding between
cyt P450 and cyt b5 is rather strong, e.g., for cyt P450 2B4 and
cyt b5, Kd values were found to be between 0.07 μM [47] and
0.2 μM [12]. Depending on the cyt P450 isoform and the
specific substrate studied, the presence of cyt b5 was found to
either enhance the metabolic turnover of cyt P450, or to have no
effect, or to even inhibit the enzymatic action of cyt P450. The
exact nature of the role of cyt b5 in the enzymatic action of cyt
P450 has puzzled investigators for several decades [13,14,73,
74]. Recent experiments have shed considerable light on the
varied effects of cyt b5 on the enzymatic activity of cyt P450.
Briefly, at low molar ratios of cyt b5 to cyt P450 reductase, cyt
b5 stimulates the activity of cyt P450 2B4 because product is
formed 10- to 100-fold faster in the presence of cyt b5 than cyt
P450 reductase, which in turn increases the utilization of
NADPH for metabolite rather than side product (H2O2+O2
−)
formation [11]. In the presence of reductase catalysis proceeds
via a long lived intermediate resulting in slower catalysis [27].
Presumably, cyt P450 is in a different conformation in the
presence of cyt b5 and cyt P450 reductase. The role of allosteric
effects in the regulation of cyt P450 has been reviewed [75]. At
high molar ratios of cyt b5 to cyt P450 reductase, cyt b5 inhibits
the activity of cyt P450 reductase because cyt b5 binds to CYP
2B4 and prevents the reductase from reducing ferric cyt P450
2B4 and initiating catalysis. Cyt b5 and reductase have over-
lapping but non-identical binding sites on the proximal surface
of cyt P450 2B4 thus prohibiting simultaneous binding of
both proteins. When the stimulatory and inhibitory effects of
cyt b5 are equal, there will be no change in the activity of the
cyt P450.
The 15-amino-acid linker region of cyt b5 is of special
interest [47]. It was found that its specific sequence of amino
acids did not seriously alter its function; even a complete
reversal of the sequence resulted in no change in function. If,
however, the linker region was shortened by 8 amino acids or
more, its function was lost completely. Therefore, a 7-amino-
acid linker is sufficient to allow a productive interaction be-
tween the heme domains on one hand, and the membrane-
binding domains on the other. The length of a seven amino acid
linker in cyt b5 is consistent with the current models of the
interaction of the two proteins with the membrane. In contrast,
lengthening the linker did not alter the ability of cyt b5 to
interact with CYP 2B4. Fig. 7 shows a hypothetical complex
between cyt P450 2B4 and cyt b5. The necessity for cyt b5 to
keep a distance of 15 to 20 Å from the membrane interface
region suggests that too short a linker region prohibits complex
formation.
2.7. Cytochrome P450 reductase and cytochrome b5 reductase
Cyt P450 reductase and cyt b5 reductase transfer electrons
from NADPH and NADH to cyt P450 and cyt b5, respectively.
Both reductases have been subjected to numerous functional
and structural studies in the past. However, structural studies of
both enzymes had to rely on truncated forms, where the
hydrophobic membrane-anchoring segment was removed in
order to reach solubilization and crystallization. In both cases,
Fig. 7. Hypothetic complex between CYP 2B4 and cyt b5. A grey bar indicates
the position of the lipid bilayer (adapted from reference [47]).
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and no hydrophobic membrane-binding patches could be
identified by applying the OPM algorithm [41] to the crystal
structures. Moreover, truncated cyt P450 reductase is incapable
of transferring electrons to cyt P450 [76]. Hence, a complete
understanding of the structure and function of both reductases
can only be gained from a study of the complete molecules,
which makes them promising targets for advanced solid-state
NMR techniques.
The enzyme NADPH-cyt P450 reductase (CPR, EC 1.6.2.4)
is a diflavin protein containing one FMN and one FAD. It
transfers reducing equivalents from NADPH to FAD to FMN,
which then transfers an electron to cyt P450 [77,78], and it is
also able to reduce cyt b5 [49,79]. It has a 6-kDa hydrophobic
N-terminal section which anchors the molecule to the endoplas-
mic reticulum and the nuclear envelope [80], and a 72-kDa
hydrophilic C-terminal section that can be freed by limited
proteolysis, but is incapable of transferring electrons to cyt P450
[76]. The truncated C-terminal section has been crystallized and
its structure determined (pdb-id 1AMO, [76]). It shows a bowl-
shaped molecule, where three domains form a bowl around a
middle space that contains the two flavin prosthetic groups and
NADPH. NADPH is bound by an NADPH-binding domain
which brings it in close proximity to the FAD prosthetic group,
which is the first electron acceptor. FAD is bound by the FAD
domain and relays the electrons to FMN, in the FMN-binding
domain. FMN finally transfers the electrons to cyt P450. The
FMN and FAD domains are joined by a ‘connecting’ domain
which allows the FMN to alternate between two conformations,
one in which it receives an electron from FAD and the second in
which it transfers an electron to cyt P450. The model structure
that was shown in Fig. 1 shows FAD in yellow and the FAD-
binding and ‘connecting’ domains in light yellow. NADPH and
NADPH-binding domain are colored blue and light blue,
respectively. The FMN-binding domain is orange and covers
the bound FMN.
NADH-cyt b5 reductase (b5R, EC 1.6.2.2) uses NADH to
reduce cyt b5 through an enzyme-bound FAD molecule [81,82].
It consists of a 3-kDa C-terminal hydrophobic membrane-anchoring domain and a 31-kDa hydrophilic catalytic segment
[83]. The X-ray crystallographic structure (1NDH [84]) shows
the catalytic segment to be made up of two domains: an
N-terminal domain that binds the prosthetic FAD group, and a
C-terminal domain responsible for binding the reducing agent
NADH in the cleft between both domains, thus bringing it in
close proximity to FAD. Fig. 1 shows FAD in yellow, the
FAD-binding domain in light yellow, and the NADH-binding
domain in light blue. NADH is not part of the crystal
structure. Cyt b5 reductase is homologous to the FAD and
NADPH domains of cyt P450 reductase.
2.8. Isotopic labeling
Most NMR spectroscopic studies of biomolecules rely on the
availability of isotopically labeled material. The NMR-active
isotopes most commonly used in biological NMR studies are 13C,
15N, and 2H nuclei. Techniques for their introduction into
biomolecules were comprehensively reviewed [85]. Uniform
15N-labeling of proteins is a long-standing standard technique
[86]. Residue-specific 15N-labeling is a strategy that will be vital
in the study of large proteins and in the assignment of 15N NMR
spectra acquired on static bilayer samples. It can routinely be
achieved using transaminase-deficient strains in expression [87],
for example DL39 strains [88]. Another strategy important in
solid-state NMR studies of membrane proteins is 13C block
labeling. Here, glucose that carries 13C nuclei only in selected
sites is fed to bacteria; bacterial metabolism ensures that only
every other carbon nucleus is labeled in the expressed protein.
This approach was originally named TEASE [89] and was
successfully applied tomagic angle spinning studies onGB1 [90].
Yet another strategy applies selective 2H-labeling to achieve
selective deuteration of methyl groups to simplify spectra [91].
Full-length cyt P450 and cyt b5 can be expressed in E. coli
and reliable high-yield purification protocols have been
established [52,92]. With the methods described above, these
protocols can easily be adapted to yield isotopically labeled cyt
P450 and cyt b5. We have already produced uniformly
15N- and
uniformly 13C,15N-labeled holo-cyt b5 at yields comparable to
the ones reached in the expression of unlabeled cyt b5.
Isotopic labeling using the 19F nucleus constitutes a very
specialized approach, since fluorine does not naturally occur in
biological macromolecules. However, the high sensitivity and
almost 100% natural abundance of the 19F nucleus may make its
incorporation into biomolecules a fruitful investment. For
example, fluoro-tryptophan has successfully been placed into
the hydrophobic core of the immunoglobulin-binding domain 1
of protein G (GB1), a protein that is attached to the membrane
by means of a myristoyl anchor [93]. Numerous other studies
introduced 19F into other membrane-associated proteins and
peptides [94–96] and soluble proteins [97–99].
3. Solid-state NMR methods applicable to static samples of
cytochromes P450 and b5
The reduced molecular mobility of proteins embedded in
membrane environments results in NMR spectra seriously
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ical shift anisotropy and dipole–dipole interactions. Therefore,
the sensitivity and resolution of spectral lines have been the
major drawbacks of solid-state NMR spectroscopy. Fortunately,
it has evolved to deal with these problems. Two general ap-
proaches are generally applied: macroscopically oriented static
samples and magic angle spinning methods [7]. These ap-
proaches and their application to membrane proteins are de-
scribed below.
3.1. Static samples in solid-state NMR
One option to deal with and exploit anisotropic nuclear
magnetic interactions is the use of macroscopically aligned
membrane samples. In a properly oriented sample, the protein
and hence its geometrical properties connected to anisotropic
nuclear interactions are restricted to individual and well-defined
orientations [100]. The result is a drastically increased spectral
resolution and the possibility of employing the measured values
of anisotropic interactions for angle measurements.
Two methods for macroscopically oriented membranes are in
widespread use today. Fig. 8 gives a graphical comparison of
both types of samples. The first type of sample is shown in the
right portion of Fig. 8. It involves stacks of glass plates where
the space between two glass plates is filled with the lipid–
protein sample to be investigated [101]. Upon hydration, the
lipids spontaneously form bilayers that orient parallel to the
glass plates. Hydration is controlled by the use of saturated salt
solutions [102]. This technique was pioneered in studies on fd
coat protein [103], gramicidin A [104], and the retinal of bac-
teriorhodopsin [105]. Our laboratory has successfully applied
this methodology extensively to address biological questions,
for example to determine the mechanism of membrane
disruption by antimicrobial peptides [106–109] and to charac-
terize the membrane interaction of cell signaling peptides [110]
and myelin basic protein [111]. Moreover, we have recently
shown that glass plate samples can be prepared over a very wide
range of temperatures [112]; and that the quality of their
orientation can be remarkably improved by using a sublimable
solid, naphthalene or para-dichlorobenzene, in the preparationFig. 8. Two types of macroscopically aligned samples are currently used in static solid
plates (right).process [113]. A mechanically oriented bilayer sample contains
thousands of lipid bilayers and therefore the NMR data mea-
sured on these samples are not influenced by the mechanically
supporting glass plates, which is unlike studies on monolayers.
Lipid bicelles constitute the second type of macroscopically
oriented sample that has found increasing attention over the last
years. When detergent molecules, such as the short-chain
phospholipid dihexanoylphosphatidylcholine (DHPC), are
added to lipid bilayers at certain concentrations, the bilayer is
disrupted into disks of bilayer patches. By means of their
geometrical shape and magnetic susceptibility properties, these
detergent/lipid aggregates can align in the external magnetic
field of the NMR spectrometer [114]. They were termed
‘bicelles’, and the fact that diacylglycerol kinase remains active
in bicelles was taken as proof of their potential for the study of
membrane proteins [115]. Today, they are routinely employed
in the study of membrane proteins [116]. The left of Fig. 8 gives
a graphic idea of the method.
Typically, bicelles align with their bilayer normal perpen-
dicular to the external magnetic field. However, this behavior
can be reversed by the addition of lanthanides, especially
ytterbium ions, Yb3+. The presence of lanthanide ions results in
a reversal of susceptibility properties and, hence, in ‘flipped’
bicelles with their normal oriented parallel to the external
magnetic field direction [117,118]. To protect embedded pro-
teins from possibly deleterious effects of the lanthanide ions, the
addition of lipid-bound chelating agents was found helpful
[119]. Use of etherlipids [120] or addition of pegylated lipids
[121] increases the long-term stability of bicelle samples.
The temperature and lipid composition that are required for
the formation of bicellar phases have been extensively inves-
tigated [122]. It has to be mentioned that the simplistic model of
bicelles as disk-shaped aggregates holds true only for a limited
range of ratios between short-chain and long-chain lipid. Under
other conditions, the morphology more resembles lipid lamellae
that are perforated by detergent pores. It has been argued that
the miscibility between long-chain and short-chain phospholi-
pids is the thermodynamic driving force behind the formation
of bicellar phases [123,124]. On the backdrop of this hypo-
thesis, it was possible to rationally design lipid mixtures that-state NMR studies of lipid bilayers. Bicelle preparations (left) and stacks of glass
Fig. 9. Peptide plane NMR interactions that allow for angle measurements in
static 15N NMR (red dipolar coupling, green two principal axes of 15N chemical
shift anisotropy).
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ranges [125]. The possibility of adjusting bicelle properties by
including different lipids will be of great interest in the study of
lipid–protein interactions. Incorporation of charged lipids will
allow the study of the influence of bilayer charge on embedded
proteins [116]; bicelles made from lipids with increased or
reduced acyl chain length allow for adjusting bilayer thickness
and thus for studying the effect of hydrophobic mismatch
[110,126]. Bicellar phases are sensitive to the presence of ions
and their concentration, with higher sensitivity to cations [127].
Lipids that were modified with biphenyl groups in their acyl
chains have been shown to form bicellar phases over a very
broad range of temperatures [128].
A third option for inducing macroscopic order was only
recently introduced. It involves anodic aluminum oxide, a
material that consists of regularly packed nanotubes with diam-
eters in the submicrometer range. Added lipid–protein mixtures
were found to align along the walls of these nanotube pores
[129]. Rhodopsin was successfully aligned in nanotubes and
was shown to retain its binding affinity for G protein [130].
Recently, we have shown the unique application of aligned
nanotubes to study the membrane disruption caused by amy-
loidogenic peptides [131].
Rotational diffusion is an important motional property
experienced by lipids and proteins in any macroscopically
oriented sample. Rotational diffusion of lipids and reconstituted
proteins occurs around the bilayer normal. For proteins and
peptides of moderate molecular size, rotational diffusion is
usually fast on the NMR time scale. The effect of rotational
diffusion on NMR spectra is that it averages all NMR inter-
actions onto the axis of rotation, thus making all NMR interac-
tions line up with the bilayer normal. Due to this effect,
multilamellar vesicles (MLVs) can potentially give the same
information as oriented samples, and the choice is mostly de-
termined by ease of preparation and sensitivity issues [132,133].
However, a study on the antimicrobial peptide PGLa found that
the differences between hydration levels present in MLVs vs.
oriented samples made of stacks of glass plates may influence
the outcome of structural measurements [134]. Bicelles
modeled as disks undergo rotational diffusion fast enough to
average the cylindrical distribution about the bicelle axis, even
in the rare cases where the protein itself does not undergo
rotational diffusion fast enough for the requisite averaging
[135]. This means that even very large proteins and protein
complexes can be studied in unflipped bicelles.
3.2. NMR spectroscopic methods custom-tailored to
macroscopically aligned samples
Proteins that are macroscopically aligned allow for angle
measurements using NMR on isotope labels. Here, we will
focus on 15N isotope labels, since these constitute the most
commonly employed isotopic label in aligned samples. The use
of 13C NMR holds promise, but is difficult to interpret since the
relationship between molecular geometry and chemical shift
anisotropy (CSA) tensor properties is difficult to predict, partic-
ularly for Cα, Cβ and Cγ nuclei in proteins [136,137].The use of 15N NMR, on the other hand, has been found to
give very straightforward and easily interpretable results. The
main reason is that magnetic interaction tensors have a well-
defined position with respect to the molecular geometry of a
peptide, and only a minor influence of amino acid type or
conformation is present [138–142]. Fig. 9 represents the par-
ticular magnetic geometry found for a 15N nucleus in a peptide
bond. The two relevant magnetic interactions are 15N chemical
shift anisotropy (CSA) and 1H–15N dipolar coupling. The
dipolar coupling between the 15N nucleus and its amide
hydrogen lines up with the bond vector. Two of the principal
values of the 15N CSA tensor are located within the plane of the
peptide bond, while the third is perpendicular to the former two.
The value of the least shielded component of the CSA tensor,
δ33, is considerably larger (approximately 210–230 ppm) than
the other two components (approximately 50–60 ppm), and it
almost lines up with the N–H bond vector [138]. However, the
directions do not coincide. They differ by an angle marked ‘θ’ in
Fig. 9; its value is usually found in the range from 10° to 25°. As
a result, a determination of both interaction values represents a
measurement of two independent physical parameters that
yields two independent constraints on molecular structure.
Polarization inversion by spin exchange at the magic angle
(PISEMA) spectroscopy [143,144] is a high-resolution method
to correlate the anisotropic 15N chemical shift with 1H–15N
dipolar couplings in a two-dimensional NMR experiment, thus
recording two independent interactions that report on molecular
geometry [145]. As a result of the well-defined magnetic
geometry in the peptide plane, PISEMA spectra of uniformly
15N-labeled proteins typically give very characteristic spectral
features. Most strikingly, α-helices result in circular spectral
patterns that are termed ‘PISA wheels’, where the acronym
stands for ‘polarity index slant angle’ [146,147]. Fig. 10 shows
how the shape of a PISAwheel changes with the orientation of
Fig. 10. PISA wheels are spectral patterns found in PISEMA spectra that
correlate 15N chemical shift and 1H–15N dipolar coupling. PISA wheels are
observed for uniformly 15N-labeled segments with α-helical secondary
structure. They report on the tilt τ of a membrane-bound α-helix with respect
to the membrane normal.
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how the observation of a PISA wheel gives a determination of
the tilt or topology of an α-helix in membranes.
Since PISEMA only makes use of local or next-neighbor
nuclear interactions, it cannot give information on sequential
connectivities within a polypeptide chain. Hence, the
assignment of peaks in a spectrum gathered on an uniformly
15N-labeled protein poses a significant obstacle in interpreting
PISEMA data. The most common strategy used today
involves the preparation of several proteins with amino-acid
type-selective 15N-labeling. The comparison of primary
sequence, secondary structure predictions, and spectral
features then usually allows the assignment of each individual
peak. This strategy has been named ‘shotgun assignment’
[148]. It has been suggested that isotropic 15N chemical shifts,
determined in independent experiments in solution, may aid
the assignment process in aligned samples [149]. Other
promising methods utilize correlation of chemical shifts of
15N or 13C nuclei and also 13C and 15N. These methods have
been demonstrated on model systems but their application to
membrane proteins is hampered by the poor sensitivity and
stability of bilayer samples.
Unfortunately, the original PISEMA sequence is very
sensitive to mismatch between the proton transmitter frequency
and 1H chemical shift positions and this effect is more pro-
nounced in experiments performed at high magnetic field
[145,150]. Because of the highly beneficial effect that very high
magnetic fields have on spectral resolution and sensitivity, this
is a strong intrinsic obstacle that needs to be overcome to make
PISEMA fully applicable to the study of membrane proteins at
high magnetic fields.
The most fruitful approach to making the PISEMA sequence
less sensitive to proton offset is to use less sensitive homo-
nuclear decoupling schemes in the indirect dimension. The
SAMMY [151] sequence employs ‘magic echo sandwiches’ to
achieve better offset stability, but gives less resolution than
PISEMA. SAMPI4 [152] is an improved SAMMY sequence
which has optimized values for critical timing periods in thesequence. The Ramamoorthy laboratory has used BLEW and
WIM homonuclear decoupling sequences in the indirect
dimension of PISEMA-type experiments that correlate 15N
chemical shift with 1H–15N dipolar coupling [153–155]. We
coined the general term ‘HIMSELF’ to refer to NMR experi-
ments that achieve ‘heteronuclear isotropic mixing by separated
local field spectroscopy’ [155]. HIMSELF sequences employ
on-resonance pulses and their performance can be further
enhanced by increasing rf field strengths, which is becoming
easier on modern spectrometers. We found all HIMSELF se-
quences to give clearly improved performance when compared
to the widely employed PISEMA sequence. An additional
advantage of HIMSELF sequences is that they are far easier to
set up on the NMR spectrometer. Besides different homonuclear
decoupling schemes, addition of refocussing pulses in broad-
band-PISEMA sequences (BB-PISEMA [156,157]) was found
to suppress offset effects. These sequences have been extended
to studies under MAS [145,158,159].
In macroscopically oriented samples of membrane proteins,
15N is by far the most commonly used isotopic label. The 13C
nucleus has only rarely been employed to date, although the
high potential of combining 13C and 15N NMR has clearly been
noticed [160,161]. More specifically, different three-dimen-
sional techniques were explored [162–164], also in combina-
tion with the SAMPI4 scheme [152,165]. They have not yet
found widespread use but have potential applications in
structural and dynamical studies of membrane proteins.
3.3. Current state of the method
Today, the study of membrane proteins embedded in macro-
scopically aligned membrane samples is routinely employed to
a variety of challenging proteins and regularly yields remark-
able insights. We want to point out just a few representative
examples: the transmembrane domain of the virus coat protein
Vpu [166], the mercury transport protein MerTf [167], the
transmembrane segment of the Influenza A virus channel M2
[168,169], and sarcolipin, an inhibitor of the sarcoplasmic Ca-
ATPase (SERCA) that has high sequence homology with
phospholamban [170]. All of these proteins were investigated in
macroscopically oriented lipid bilayers; site-selective labeling
allowed full assignments and consecutive structural calcula-
tions. Considerably larger proteins were also incorporated into
bicelles, some examples include CXCR1, a G-protein-coupled
receptor (GPCR) for interleukin-8 (IL-8) [171]; several mem-
bers of the FXYD family of transport proteins [172,173]; outer
membrane protein A (OmpA) [174]; and recent studies on
cytochromes b5 and P450 as discussed below. In all cases, use
of uniformly 15N-labeled protein resulted in severely crowded
one-dimensional spectra; even PISEMA spectra yielded suf-
ficient spectral resolution only on site-selectively 15N-labeled
material.
A completely different experimental strategy involves labeling
of protein with deuterated methyl groups. Site-selective labeling
of the 64-kDaABCmultidrug efflux pumpLmrAwith alanine-d3,
and subsequent 2H NMR in static liposomes allowed the study of
local flexibility in substrate-free and -bound states [175].
Fig. 12. One-dimensional 15N NMR spectra of uniformly 15N-labeled cyt b5 in
DMPC/DHPC bicelles. The spectral intensity crowds in the regions 40 to
90 ppm and 100 to 130 ppm, and both regions show differing intensities in
different polarization transfer schemes. This observation is attributed to the
different mobilities of the domains of cyt b5. The molecular cartoon on top is
meant to reflect our assignment of spectral regions to molecular domains. The 40
to 90 ppm spectral contribution is assigned to the α-helical transmembrane
domain, while the 100 to 130 ppm contribution reports on the soluble domain.
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We have conducted experiments on uniformly 15N-labeled
cyt b5 in bicelles composed of dimyristoylphosphatidylcholine
(DMPC) and dihexanoylphosphatidylcholine (DHPC) [176].
As a basis for all further experiments, we first determined
how the presence of cyt b5 influenced the quality of bicelle
orientation. The most straightforward way to determine bicelle
orientation is by 31P NMR spectroscopy of the phosphate
groups in DMPC and DHPC. Fig. 11 gives representative
spectra recorded on pure bicelles and bicelles in the presence of
two different concentrations of cyt b5. A control bicelle without
protein shows two resonances in 31P spectra, one caused by
DHPC, the other by DMPC, both are observed upfield from the
isotropic chemical shift position. Their narrow linewidth shows
that a very high quality of orientation is reached. The exact
position of the DMPC line gives an indication of the overall
‘wobble’ of the DMPC bilayer patch of the bicelle; in the top
spectrum of Fig. 11 the bicelle wobble can be described by an
order parameter of approximately Sbicelle=0.9. The presence of
cyt b5 at a ratio of 1.2 mol% cyt b5 per DMPC was found to
seriously interfere with bicelle orientation. Only when the
content of cyt b5 was lowered to 0.47 mol%, was the quality of
bicelle alignment comparable to the control bicelles (middle and
bottom of Fig. 11).
The described parameters were subsequently used to orient
uniformly 15N-labeled cyt b5 in DMPC/DHPC bicelles. Fig. 12
shows 15N NMR data acquired on these samples. Cross-
polarization (CP) was used to transfer magnetization from 1H to
15N nuclei. Remarkably, very different spectral shapes are
observed for different CP contact times. At very short contact
times (bottom spectrum in Fig. 12), signal is observed mostly in
the region 40 to 90 ppm, while at long contact times (middle),
signal is observed between 100 and 130 ppm. This same region,
which is centered around the isotropic chemical shift values of
amide 15N nuclei, shows intensity when polarization transfer is
done by RINEPT (refocused insensitive nuclei enhancement
by polarization transfer [177]) instead of CP. The RINEPTFig. 11. A scheme of cytochrome b5 in bicelles and
31P NMR spectra at different
protein:lipid ratios reporting on the achieved quality of macroscopic alignment.sequence is usually employed in solution-state NMR and allows
the transfer of magnetization in highly mobile molecular
segments in the solid-state. The RINEPT spectrum is shown
in Fig. 12 (top), it also shows improved spectral resolution when
compared to the CP spectra. Note that spectral resolution could
potentially be increased by flipping the bicelles by the addition
of lanthanide ions (see Section 3.1). In the case of cyt b5 in
bicelles, however, we found that the addition of Yb3+ destroys
the sample (unpublished results).
The molecular topology of cyt b5 offers a straightforward
explanation of the observed spectral properties. The transmem-
brane anchor is expected to be a fairly rigid entity, since it is
immobilized by the surrounding lipid bilayer. The soluble
domain, on the contrary, is only loosely tethered to the mem-
brane anchor, and is therefore expected to be very mobile. It is
straightforward, then, to assume that the signal in the region 40
to 90 ppm is caused by the transmembrane anchor, while the
region 100 to 130 ppm reports on the mobile region. This
assignment is reflected by the scheme of cyt b5 included in Fig.
12; it is based on the fact that cross-polarization at short contact
times cross-polarizes rigid molecular segments while long con-
tact times are needed to excite mobile segments. The assign-
ment was strongly supported by a deuterium exchange
experiment that was used to identify solvent exposed portions
of the molecule [178]. Only the signal in the 40 to 90 ppm
range, that we identify with the transmembrane anchor domain,
was not quenched in the deuterium exchange experiment [176].
We want to emphasize that the spectral editing techniques
presented here will prove to be very useful in the study of any
membrane protein, since membrane proteins typically have
multiple domains which will often exhibit widely different
dynamic properties.
Fig. 14. Molecular models (left) and corresponding predicted 2D HIMSELF
spectra (right) for full-length cyt b5 (top) and a more detailed model of the
transmembrane domain alone (bottom). The very crude model of full-length cyt
b5 reproduces the observed spectral features fairly well, while the OPM
algorithm [41] predicts too large a tilt for a kinked α-helix and gives a poor
reproduction of spectral features.
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uniformly 15N-labeled cyt b5 in DMPC/DHPC bicelles to 2D
HIMSELF experiments that correlate 15N chemical shift with
1H–15N dipolar coupling. Fig. 13 shows the well-resolved
resonances of the HIMSELF spectrum recorded on uniformly
15N-labeled cyt b5. Most interestingly, it resolves the spectral
region from 40 to 90 ppm into a clearly discernible PISAwheel
pattern. This again confirms our assignment of the spectral
region to the α-helical transmembrane domain of cyt b5. When
compared to theoretical PISAwheels, it became evident that our
HIMSELF spectrum cannot be fitted with a single perfect PISA
wheel. This indicates that the transmembrane region of cyt b5
does not form a perfectly straight α-helix. The presence of
a proline residue in the middle of the putative membrane
region may cause it to be kinked (see [176] and Section 3.5 on
next page).
To compare our experimental HIMSELF spectra to a simu-
lated one, we generated a model structure of cyt b5. We used the
NMR structure 1DO9 [57] of the soluble domain as a starting
point and added the missing residues in a purely hypothetical
fashion. The linker region was modeled as a random coil, while a
perfect α-helix was chosen for the transmembrane domain. The
resulting model structure for full-length cyt b5 is shown in the
upper left panel of Fig. 14. It was used as input for the SIMMOL
program [179] to generate a simulated HIMSELF spectrum that
is shown in the upper right of Fig. 14. Interestingly, this very
rough model is already able to reproduce key spectral features.
Namely, the PISA wheel pattern resembles the one observed
experimentally, and the small dipolar coupling values observed
for the soluble domain between 100 and 130 ppm are also similar
to the experimental ones.
In a subsequent step, we wanted to generate a more realistic
model for the transmembrane α-helix. The program FrameworkFig. 13. Two-dimensional 1H–15NHIMSELF spectrum of uniformly 15N-labeled
cyt b5 in DMPC:DHPC bicelles. The spectrum shows well-resolved resonances
and a clearly discernible PISAwheel pattern. Best-fit analysis of the PISAwheel
(dashed red circle) shows that the transmembrane α-helix is tilted 15° (±3°) with
respect to the bilayer normal, but indicates that it deviates from perfect α-helical
geometry.[180] was used to predict the exact extent of the α-helical
secondary structure. The backbone geometry of a typical kinked
α-helix was extracted from a random structure (pdb-id 2BL2).
Sidechains were added according to the sequence of rabbit cyt
b5. The orientation of the resulting model structure was pre-
dicted using the OPM algorithm [41]. OPM predicts a tilt of
approximately 30° with respect to the bilayer normal, far larger
than the experimentally observed tilt value of ∼15° (±3°).
Consequently, the HIMSELF spectrum predicted for the model
has almost no resemblance to the experimental data. Model
structure and predicted spectrum are shown in the lower panels
of Fig. 14.
We mentioned the possibility of changing the lipid com-
position in bicelles in Section 3.1 above. This way, the bicelle
sample can be made to more closely mimic the physiological
lipid compositions, or the temperature range in which the
macroscopically aligned bicellar phase is formed can be
adjusted. In future experiments on both cyt b5 and cyt P450,
it may prove necessary to choose a lipid system that forms
bicelles in a lower temperature range in order to keep cyt P450
stable and avoid degradation over the course of several days
necessary to conduct two- or three-dimensional experiments.
For the time being, we investigated uniformly 15N-labeled
cyt b5 in bicelles with increased bilayer thickness and with a
partial negative charge. Fig. 15 summarizes our results. The first
column repeats the one- and two-dimensional 15N NMR spectra
of cyt b5 in dimyristoylphosphatidylcholine (DMPC)/dihex-
anoylphosphatidylcholine (DHPC) bicelles that were shown in
Fig. 16. Helical net representation of the α-helical membrane anchor of rabbit
cyt b5. Color coding indicates the polarity properties of residues: yellow
hydrophobic, green polar, blue positively charged, and red negatively charged.
Fig. 15. One-dimensional 15N NMR (top) and two-dimensional HIMSELF spectra (bottom) of rabbit cyt b5 in different bilayer environments. The first column shows
spectra acquired in dimyristoylphosphatidylcholine (DMPC)/dihexanoylphosphatidylcholine (DHPC) bicelles, in the second column dipalmitoylphosphatidylcholine
(DPPC) instead of DMPC was used to make bicelles, in the third column a mixture of 1:4 dimyristoylphosphatidylglycerol (DMPG)/DMPC was used instead of
DMPC alone. The spectra in the fourth column were recorded in the presence of unlabeled rabbit CYP 2B4 in DMPC/DHPC bicelles.
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dipalmitoylphosphatidylcholine (DPPC)/DHPC bicelles that
have an increased hydrophobic thickness of 26.3 Å, as
compared to 22.8 Å in DMPC/DHPC bicelles [126]. The
third column shows data acquired on bicelles where DMPC and
dimyristoylphosphatidylglycerol (DMPG) at a molar ratio of
4:1 were used as the long-chain phospholipid component;
DMPG carries a negatively charged headgroup and gives the
lipid bilayer an overall negative charge. It is obvious from the
spectra of Fig. 15 that the exact biophysical nature of the
membrane environment has an impact on the structure of cyt b5.
The observed PISAwheels clearly change their appearance, but
they roughly retain their overall extension. This indicates that
the tilt of the transmembrane domain remains fairly constant,
and that it is not influenced by the hydrophobic mismatch
between the length of the TM region of the protein and the
hydrophobic length of lipid bilayers. At the moment, however, a
more detailed structural interpretation is not possible, since
complete assignment of resonances in the HIMSELF spectra
has not been completed. We plan to investigate selectively
15N-labeled cyt b5 to give a spectral assignment and to reach an
atomic-level conclusion on cyt b5 structure. In addition, the
well-behaved bicelles containing cyt b5 will be used to develop
resonance assignment solid-state NMR methods to study other
membrane proteins.
Another very interesting possibility would be to include
cholesterol into the bicelles. This approach has been tested
before [181], and it would be especially promising for the study
of cyt P450 isoforms that metabolize sterols. Comparison of
data acquired in DMPC/DHPC bicelles and in bicelles
containing sterols may allow insights into the substrate binding
of these particular cyt P450 isoforms.3.5. Structural aspects of the α-helical transmembrane anchor
of cyt b5
The two-dimensional solid-state NMR spectra of uniformly
15N-labeled cyt b5 that were reviewed in the preceding section
represent the first structural studies on full-length cyt b5. To
fully understand these spectra, and the full-length protein, it
will be essential to understand the structural properties of the
C-terminal transmembrane segment. It was previously estab-
lished that this segment is α-helical [46] and most likely spans
the bilayer of the endoplasmic reticulum [53]. In the following
paragraphs, we want to point out some peculiarities in its
primary structure that may be indications for its actual three-
dimensional conformation and its detailed interaction with the
membrane of the endoplasmic reticulum.
The primary sequence of the transmembrane domain of cyt
b5 is far less conserved than that of the soluble domain [13,46].
Here, we will focus on the transmembrane domain of micro-
somal rabbit cyt b5, since this protein is under investigation in
our laboratories (see above, below, and [176]). Fig. 16 gives a
Fig. 17. 31P chemical shift spectra show good quality of alignment for bicelles
containing both cyt P450 and cyt b5. The peak at ∼3 ppm is due to phosphate
buffer.
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representation gives an idea of the distribution of hydrophilic
and hydrophobic residues in an α-helical conformation; color
distinguishes between hydrophobic (yellow), polar (green), and
positively (blue) or negatively (red) charged residues [183]. The
most likely extension of the transmembrane stretch is marked by
three tryptophan residues on the N-terminal and two tyrosines
on the C-terminal side. Both tryptophan and tyrosine are
typically found in bilayer interfaces.
The helical net representation reveals a couple of peculiar
features. First, the α-helix does not seem to be extraordinarily
hydrophobic, as would be expected from a segment spanning
the hydrophobic core of a lipid bilayer. Especially toward its
N-terminus, it consistsmostly of polar residues. Second, a proline
residue is found in the putatively membrane-spanning stretch.
This is not at all unusual, as proline is often present in trans-
membrane α-helices, where it regularly induces kinks due to
steric clashes [184]. Kink angles induced by Prowere found in the
range from 5° to 60°.
Both mentioned peculiarities may be related to the fact that cyt
b5 is able to spontaneously insert into lipid bilayers. A GxxxG
motif, which is typical for oligomerization interfaces on
transmembraneα-helices [185–187], is not present in the primary
sequence of the cyt b5 transmembrane domain. Our experiments
confirm that the transmembrane domain forms a distortedα-helix;
we are currently aiming for spectral assignments to identify the
proline 15N NMR resonances and their location within the
transmembrane domain (see above and [176]).
3.6. Studies of the interaction of cyt P450 with cyt b5
To explore the prospects of studying cyt P450 in lipid
bicelles, we pre-formed a 1 mM cyt b5-cyt P450 complex that
was then incorporated into 3.5:1 dimyristoylphosphatidylcho-
line (DMPC)/dihexanoylphosphatidylcholine (DHPC) bicelles.
The molar ratio between cyt P450, cyt b5, and DMPC was
1:1:500. We recorded 31P NMR spectra that indicated a very
good degree of alignment, shown in Fig. 17. To find out
whether actual incorporation of cyt P450 had occurred and
whether any interaction between cyt P450 and cyt b5 could be
detected, we repeated the sample preparation, this time using
uniformly 15N-labeled cyt b5. The resulting one- and two-
dimensional 15N NMR spectra are shown in the fourth column
of Fig. 15. The one-dimensional spectra show distinct changes
in the spectral shape. In general, spectra recorded using schemes
that favor the detection of mobile regions (CP at 3.0-ms contact
time, and RINEPT) show reduced spectral intensity, while CP at
0.1-ms contact time, which targets rigid regions, shows in-
creased spectral intensity. This observation is in very good
agreement with a reduced mobility of cyt b5, especially its
soluble domain, upon binding to cyt P450. The 2D HIMSELF
spectrum confirms the presence of structural changes, but does
not hint at a change in the tilt angle of the membrane anchor.
These preliminary results demonstrate that cyt P450 can be
studied in bicelle samples, that the preparative effort of making
these samples is limited, and that cyt P450 is stable for the time
necessary to record 2D NMR spectra. These observations arevery encouraging and open new prospects for structural studies
of full-length cyt P450.
3.7. Static NMR experiments on cytochrome P450
We were able to incorporate a pre-formed cyt b5–cyt P450
complex into lipid bicelles with surprisingly little preparative
effort (see preceding Section 3.6). Protein concentrations
reached were high enough to conduct 2D NMR experiments.
These observations prove that it will be possible to subject
uniformly 15N-labeled cyt P450 to similar experiments. Using
HIMSELF experiments on cyt P450 in bicelle samples, it will
be possible to study the full-length protein in bilayer
environment, a feat that cannot be achieved by other structural
methods. Such experiments may reveal how cyt P450 is bound
to the membrane and which residues in addition to those in the
N-terminal α-helix are incorporated in the membrane. More-
over, the use of bicelles of different lipid compositions will
show how sensitive cyt P450 structure is to the exact nature of
the surrounding bilayer, and they may be able to show structural
changes in the presence or absence of substrate. Especially
interesting will be the study of sterol substrates that can be co-
embedded into the lipid bilayer.
To assess the information that static 15N NMR studies on
macroscopically aligned cyt P450 may yield, we simulated a set
of HIMSELF spectra for different structures of CYP 2B4. Three
crystal structure determinations have been carried out for a
truncated form of this enzyme. As discussed in Section 2.3, the
structure with pdb-id 1SUO was determined in the presence of a
small inhibitor molecule and shows a very compact conforma-
tion that tightly encloses the inhibitor. The presence of a bulky
inhibitor in 1PO4 leads to a somewhat more ‘open’ structure,
while in the absence of an inhibitor (2BDM) a conformation
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cule binding to the heme of the second cyt P450 molecule. For
all three structures, we downloaded the prediction for its
orientation with respect to the lipid bilayer as generated by the
OPM algorithm [41]. Fig. 18 shows ribbon representations of
the three structures, a blue line shows the predicted location of
the bilayer interface plane. The ribbon representations were
generated with MOLMOL [188].
Along with each structure shown in Fig. 18, the cor-
responding HIMSELF spectrum as calculated with SIMMOL
[179] is shown. As described in Section 3.2, HIMSELF spectra
correlate anisotropic 15N chemical shift and 1H–15N dipolar
couplings that are found in the peptide bond amide groups.
They give characteristic spectra reporting directly on the
conformation of the protein backbone. The HIMSELF simula-
tions of Fig. 18 show very crowded spectra, as expected from
the large molecular size of cyt P450. There are, however, clearly
discernible differences between the spectra that directly report
on the differences in structure. We conclude that HIMSELF is a
promising approach to study subtle differences in cyt P450
conformation, but the expected HIMSELF spectra are very
complex. Hence, they will need to be complemented with
selective labeling, spectral editing, or three-dimensional spec-
troscopic techniques. Another promising approach will be to
apply magic angle spinning (MAS) techniques in addition to the
static techniques discussed so far. The following portion of theFig. 18. Model structures and corresponding predicted HIMSELF spectra of different
truncated forms (top row). The X-ray structures represent different conformations fou
are marked by the name of the bound inhibitor and their protein data bank ID numb
representations generated with MOLMOL [188], a blue line denotes the predicted p
HIMSELF spectra correlating 15N anisotropic chemical shift with 1H–15N dipolar carticle will introduce MAS techniques and the great promise
they hold for the study of membrane proteins.
4. Magic angle spinning solid-state NMR methods
4.1. The great promise of magic angle spinning methods
In solution-state NMR spectroscopy [5,6], multidimensional
techniques are a standard tool to spectroscopically establish
through-bond aswell as through-space connectivities between the
1H nuclei in a polypeptide. Taken together, these connectivities
give the necessary information to identify spin systems, trace
sequential connectivities along the protein backbone, and identify
the resonance of every individual 1H nucleus in the molecule. In
consecutive experiments, non-trivial distance constraints can be
recorded that report on the local secondary structure or on long-
range contacts between regions of the molecule that are in spatial
proximity. Ultimately, the sum of all measured constraints are
useful to determine and refine a protein structure.
Because of limitations in the range of isotropic chemical
shifts of protons, and the dominance of residual anisotropic
interactions, a parallel route is not viable in solid-state NMR.
The 13C nucleus, in contrast, has a far wider range of isotropic
chemical shifts. Its lower gyromagnetic ratio makes it less
sensitive than the 1H nucleus, a disadvantage that also has an
advantageous side effect: residual 13C–13C dipolar couplingsforms of CYP 2B4. Model structures of CYP 2B4 constructed from X-ray data of
nd for the enzyme in the presence and absence of inhibitors. The three structures
er. Predicted membrane alignment according to the OPM database [41], ribbon
osition of the membrane interface region. The bottom row is the predicted 2D
oupling parameters.
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MAS. To make use of 13C NMR spectroscopy for the use of
unordered protein samples, the first necessary step is to suppress
all anisotropic interactions. This is achieved by fast spinning of
the sample at the magic angle. Once the bulk of anisotropic
interactions is suppressed by MAS, individual anisotropic in-
teractions can selectively be reintroduced by specifically
designed rf pulse sequences to exploit them for structural mea-
surements [189]. The interaction that is most interesting for the
measurement of molecular proximity and distances is dipolar
coupling. Using different experimental schemes, dipolar cou-
pling can be employed to transfer magnetization along a poly-
peptide chain. For example, the CTUC scheme [190] transfers
magnetization through bonds (or scalar coupling), while
protein-driven spin diffusion (PDSD [191]) and dipolar-assisted
rotational resonance (DARR [192]) are used to establish
through-space (or dipolar coupling) correlations. Fig. 19 gives
an idea how different experimental schemes are used to transfer
magnetization along different pathways along a protein
backbone. The source of magnetization is usually provided by
cross-polarizing 15N nuclei in the peptide bond (shown green in
Fig. 19). Triple-resonant NCOCA (pink) and NCACB (light
blue) experiments are employed to transfer magnetization first
to the adjacent carbonyl or alpha carbon, respectively, then into
the amino acid sidechain. Hence, sequential walks and reso-
nance assignments for 13C nuclei can be reached that closely
parallel those known from solution-state 1H NMR.
Non-trivial distance constraints can be measured in experi-
ments that make use of the high gyromagnetic ratio of the 1H
nucleus, which makes dipolar couplings detectable even over
long distances. 13C or 15N nuclei that are directly bonded to the
hydrogens of interest are used first to cross-polarize 1H nuclei,
then to read out the dipolar coupling value using the siteFig. 19. Schematic of a polypeptide backbone with indication of the most
important polarization transfer schemes in 13C MAS NMR (pink NCOCA, light
blue NCACB, light green NHHC, with through-space transfer indicated by the
long arrow with dashed outline).specificity supplied by assigned 13C resonances. Depending on
whether they make use of 13C or 15N nuclei as a source of
magnetization, such experiments are referred to as CHHC
or NHHC experiments, respectively. The magnetization transfer
pathway of an NHHC experiment is indicated in light green in
Fig. 19.
Once an assignment is reached, the isotropic 13C chemical
shift values of 13Cα and
13Cβ nuclei give information on local
secondary structure, since their values are closely correlated
with the Ramachandran torsion angles [193]. In addition,
dedicated experiments have been proposed to measure torsion
angles [194]. Analyzed together with a sufficient number of
non-trivial distance constraints, the described strategy opens a
way to de novo structure determination for membrane proteins.
The described strategy has been reviewed [195–198], and
more developments continually keep appearing in the literature.
Three-dimensional schemes are regularly employed to alleviate
spectral overlap and help the assignment process [199]. The
feasibility of this approach was originally validated on small,
very compact and stable proteins or protein domains, such as the
α-spectrin SH3 domain [90,200], the β1 immunoglobulin
binding domain of protein G (GB1) [201,202], and ubiquitin
[203–205]. In all these studies, sample preparation conditions
were found to be vital to obtain sufficiently resolved spectra; the
sample preparation has to ensure that the protein has micro-
crystalline form, i.e., very well-defined structural properties at
the molecular level.
4.2. Current state of the method
The feasibility of obtaining sequential assignments, to con-
secutively determine non-trivial distance constraints, and to
ultimately determine de novo protein structures, was initially
demonstrated on microcrystalline model proteins. Today, it is
increasingly applied to membrane proteins of high physiolog-
ical relevance in a lipid bilayer environment. We want to point
out some examples of proteins investigated. In all cases, the
importance of optimized sample preparation conditions was
confirmed as prerequisite for high-resolution spectra.
The binding of kaliotoxin, a scorpion toxin, to a chimeric
potassium channel (KcsA-Kv1.3) was studied [206]. It was
possible to identify residues in the selectivity filter region of the
protein and to observe structural changes upon toxin binding.
For sensory rhodopsin, a G-protein-coupled receptor (GPCR),
reverse labeling was used for the resolution and assignment of
numerous residues and for the determination of whether they
were rigid or mobile [207]. Phospholamban consists of a trans-
membrane anchor and a soluble domain, giving it a topology
similar to that of cyt b5. It modulates calcium transport by the
sarcoplasmic Ca-ATPase (SERCA). Solid-state 13C MAS NMR
was used to determine the structure of phospholamban in lipid
vesicles that showed a rigid α-helical transmembrane domain
and a disordered soluble domain [208], which is very different
from other reported structures [209–211]. For DsbB, a four-
helix transmembrane bundle, a partial assignment of 13C
resonances was reported [212]. The lipidated membrane
anchor of human N-Ras, a small monomeric GTP-binding
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very large membrane proteins, such as outer membrane protein
G (OmpG, [214]), 13C MAS NMR studies were carried out and
the reported results are encouraging. Due to the size of the
investigated proteins, the number of observed resonances does
not yet allow for their proper resolution and assignment. The
largest target to date was cytochrome bo3 oxidase, a 144-kDa
complex of membrane proteins [215]. MAS studies are also
reported on lipid–protein complexes that resemble high-density
lipoprotein (HDL) and offer a potential novel membrane
mimetic. Their protein component was investigated in 13C
MAS NMR, which was able to distinguish between two
conformational models [216].
A somewhat simpler approach deals with the conformation
of ligand molecules when bound to their receptor [217]. Here,
only the ligand (typically a fairly small molecule) needs to be
isotope labeled, while the receptor is supplied in unlabeled
form. The binding of neurotensin to its receptor [217–219] and
the binding of neurotoxin II to the nicotinic acetylcholine
receptor [220] have been studied in this fashion.
4.3. 13C MAS NMR of cytochrome b5
To reach a full structural picture of full-length cyt b5, we plan
to apply the full array of 13C MAS NMR techniques as
described above. We prepared uniformly 13C,15N-labeled cyt b5
and are currently investigating under MAS conditions in
bicelles. To give an idea of the quality of spectra obtained on
these samples, Fig. 20 shows 1H-13C heterocorrelation spectra
that were recorded with two different polarization transfer
schemes. The left spectrum was recorded with cross-polariza-
tion at 3-ms contact time, while the one on the right used
RINEPT [177] to transfer magnetization from proton to carbon
nuclei. Similar to what was observed in 15N NMR [176],
individual portions of the protein have markedly different
spectroscopic properties because their dynamics is different.
The more rigid regions of cyt b5 are observed in the cross-
polarization experiment, and they yield fairly broad lines due to
their rigid nature. In RINEPT, the highly mobile soluble domain
is observed, and its mobility results in far more narrow spectralFig. 20. 2D 1H–13C heteronuclear chemical shift correlation spectra acquired on fu
spectrum, CP polarization transfer was used, while the spectrum to the right was acqu
regions of the molecule are observed with strong differences in linewidth.lines. Thus, it is evident that employing multiple schemes for
polarization transfer allows for spectral editing that addresses
the domains of cyt b5 individually. We want to repeat our
belief that this fact will greatly help in the spectroscopic study
of full-length cyt b5. This will most probably also hold true in
the study of cyt P450, or any membrane protein that has large
cytosolic portions, which means basically the large majority of
biologically relevant membrane proteins.
Some earlier studies have made use of motional properties of
proteins or protein domains in a similar fashion. In phospho-
lamban, the membrane-bound and cytosolic domains were
found to have markedly dissimilar dynamic properties; custom-
tailored multi-dimensional techniques established 13C–13C
homocorrelations for each domain individually, giving a good
idea of overall protein structure [208]. Studies on site selectively
13C-labeled rhodopsin determined the local mobility of the
labeled sites by comparing their behavior in cross-polarization
and direct polarization transfer schemes [221,222]. In crystal-
line ubiquitin, it was possible to measure order parameters for
each individual peptide bond [223].
4.4. 13C MAS NMR of cytochrome P450
Our experiments indicate that cyt P450 2B4 can fairly easily
be incorporated into lipid bilayer environments suitable for
MAS NMR studies. This will allow us to study uniformly
13C,15N-labeled cyt P450 in 13C MAS NMR experiments. In
this context, related structural studies on the soluble domain of
cyt P450 need to be pointed out. These have used either pre-
cipitated truncated cyt P450 (i.e., free of the membrane anchor)
for solid-state NMR studies, or have subjected full-length
membrane-embedded protein to other structural techniques.
Bacterial cyt P450cam was co-precipitated together with the
perdeuterated substrate adamantane using ammonium sulfate
[224]. Kinetic details of substrate binding and substrate dis-
placement by a higher affinity substrate, camphor, were studied
using 2H NMR. CYP BM-3 is a cyt P450 from Bacillus
megaterium that contains its own reductase domain instead of a
separate reductase enzyme. Site specifically 13C- and 15N-
labeled CYP BM-3 was prepared and its binding to the substratell-length cyt b5 embedded in DMPC:DHPC bicelles under MAS. For the left
ired using refocused INEPT [177]. Due to differences in their mobility, different
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PEG-8000 [225]. Unique spin pairs could be identified by the
labeling scheme; it was shown that a phenylalanine residue
in the binding pocket changes its conformation upon sub-
strate binding. Subsequently, CYP BM-3 and NPG binding was
studied at different temperatures and an indication was found
that the substrate shifts to a different position closer to the heme
iron upon increasing the temperature [226]. This observation
may explain why crystal structures often have the substrate
located quite far away from the active site. Possibly a higher,
i.e., more physiological, temperature is necessary to shift the
substrate to an enzymatically competent position. CYP BM-3
was also studied in molecular dynamics simulations. A replica
exchange molecular dynamics study focused on conformational
equilibria [227], another molecular dynamics study investigated
the dynamics of the bound substrate NPG [228].
Cyt P450 [229,230] and cyt P450 reductase [231] were
successfully reconstituted into ‘nanodisks’, discoidal lipid–
protein aggregates that consist of two mostly α-helical,
proteinaceous ‘rings’ or ‘belts’ holding a lipid bilayer patch in
their interior. After depositing the protein-nanodisk complexes
on mica surfaces, it was possible to use atomic force micros-
copy to study the topology of their cytosolic domains. The
incorporation of cyt P450 into nanodisks may also be a way to
prepare cyt P450 samples suitable for 13C NMR spectra, since it
has been demonstrated that precipitated nanodisks give well-
resolved 13C MAS NMR spectra [216].
5. Data analysis schemes and software approaches
A number of sophisticated software applications are
available that facilitate the analysis of data acquired in solid-
state NMR spectroscopy in terms of molecular structure. The
programs Xplor-NIH [232] and CNS [233] were originally
developed to analyze distance constraints measured on mole-
cules in solution. Both programs, however, can also account for
orientational constraints with respect to an outside frame of
reference. Currently this functionality is used for residual
dipolar couplings (RDC) but can easily be extended to dipolar
couplings measured in static samples. A dedicated package,
CNS-SS02, is available for CNS that was designed to do atomic
structural refinement with correlated solid-state NMR restraints
[234]. The program TALOS [235] is capable of extracting
Ramachandran angles from secondary chemical shift data for
13Cα and
13Cβ positions [193,236]; these constraints can
subsequently be introduced as constraints into structural
calculations. The program COSMOS [237] integrates distance
and angular constraints with the use of chemical shift data for
structural calculations and refinements.
6. Experiments to study protein-lipid interaction
The topology of a membrane protein with respect to the lipid
bilayer environment can be studied in different ways. The
presence of lanthanide ions quenches NMR resonances. Hence,
addition of lanthanide ions to the hydration water of a bilayer
sample is a useful method to distinguish solvent-exposed fromsolvent-hidden portions of the protein [238–240]. In the case of
cyt b5 in bicelles, however, we found that the addition of
manganese ions destroys the sample (unpublished results).
Similarly, replacing the buffer with D2O can be used to
exchange amide protons for deuterons, thus suppressing signal
from the solvent exposed portions of the protein [178]. In the
case of cyt b5, this method was successfully used to unam-
biguously identify the transmembrane domain (see above).
A membrane protein exerts a distinct effect on the sur-
rounding lipid bilayer. Several experimental methods can deter-
mine this influence by measuring the 1H–13C dipolar couplings
present in the natural abundance 13C nuclei of the lipids. In
macroscopically oriented samples, PDLF [241,242] and
SAMMY [243] schemes were used to determine site-resolved
1H–13C dipolar couplings and, thus, order parameter profiles
for the phospholipid DMPC. The quality of the observed one-
dimensional 13C NMR spectra was found to be highly depen-
dent upon the heteronuclear decoupling scheme employed
[244]. In non-oriented multilamellar samples under magic angle
spinning, recoupling schemes need to be employed to measure
1H–13C dipolar couplings [245,246]. A recoupled PDLF
scheme was found to be particularly useful [245].
7. Conclusion and perspective
The present contribution provides a synopsis of the current
state of structural studies on cyt P450 and cyt b5 as well as of the
possibilities of modern solid-state NMR spectroscopic methods.
In particular, the benefits of solid-state NMR under both static
sample and magic angle spinning conditions using bicelles have
been described. These methods have sufficiently matured to soon
be applied as standard tools in the study of anymembrane protein.
We hope we have demonstrated the great promise contained in
applying modern solid-state NMR techniques to both cyt P450
and cyt b5. Solid-state NMR of these molecules in a bilayer
environment will make it possible to address many questions that
are beyond the reach of the experimental techniques applied
today. On the spectroscopic side, we expect the combination of
static and MAS techniques to give sufficient accessible
information to form a complete picture of the conformation,
topology, and dynamics of cyt P450 and cyt b5. In the case of cyt
b5, we think that a complete de novo structure determination in a
membrane environment is a viable mid-term goal.
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